In several in vitro tests, its anti-proliferative activity against tumour cell lines has been demonstrated, and due to its ability to specifically inhibit the UCP2 protein and inhibit STAT3 activation, a significant increase in the cytotoxicity of several anticancer drugs was observed in co-treatment with genipin. The gene discussed is UCP2; the disease is neoplasm.